Catalyst Wire Dossier Catalyst Wire Dossier

ENV515 Travoprost Extended Release (XR)

travoprost extended-release · Envisia Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENV515 Travoprost Extended Release (XR), covering 2019-10-17 to 2019-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma [Phase 2]

See pricing